Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 3
2000 4
2001 2
2002 2
2003 2
2004 4
2005 6
2006 6
2007 22
2008 8
2009 16
2010 5
2011 5
2012 11
2013 11
2014 9
2015 17
2016 7
2017 7
2018 7
2019 12
2020 17
2021 16
2022 10
2023 17
2024 14
2025 11

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

217 results

Results by year

Filters applied: . Clear all
Page 1
Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease.
Sabatine MS, Giugliano RP, Keech AC, Honarpour N, Wiviott SD, Murphy SA, Kuder JF, Wang H, Liu T, Wasserman SM, Sever PS, Pedersen TR; FOURIER Steering Committee and Investigators. Sabatine MS, et al. N Engl J Med. 2017 May 4;376(18):1713-1722. doi: 10.1056/NEJMoa1615664. Epub 2017 Mar 17. N Engl J Med. 2017. PMID: 28304224 Free article. Clinical Trial.
A prospective natural-history study of coronary atherosclerosis.
Stone GW, Maehara A, Lansky AJ, de Bruyne B, Cristea E, Mintz GS, Mehran R, McPherson J, Farhat N, Marso SP, Parise H, Templin B, White R, Zhang Z, Serruys PW; PROSPECT Investigators. Stone GW, et al. N Engl J Med. 2011 Jan 20;364(3):226-35. doi: 10.1056/NEJMoa1002358. N Engl J Med. 2011. PMID: 21247313 Free article. Clinical Trial.
Interatrial Shunt Treatment for Heart Failure: The Randomized RELIEVE-HF Trial.
Stone GW, Lindenfeld J, Rodés-Cabau J, Anker SD, Zile MR, Kar S, Holcomb R, Pfeiffer MP, Bayes-Genis A, Bax JJ, Bank AJ, Costanzo MR, Verheye S, Roguin A, Filippatos G, Núñez J, Lee EC, Laufer-Perl M, Moravsky G, Litwin SE, Prihadi E, Gada H, Chung ES, Price MJ, Thohan V, Schewel D, Kumar S, Kische S, Shah KS, Donovan DJ, Zhang Y, Eigler NL, Abraham WT; RELIEVE-HF Investigators. Stone GW, et al. Among authors: verheye s. Circulation. 2024 Dec 10;150(24):1931-1943. doi: 10.1161/CIRCULATIONAHA.124.070870. Epub 2024 Sep 23. Circulation. 2024. PMID: 39308371 Free PMC article. Clinical Trial.
DynamX sirolimus-eluting Bioadaptor versus the zotarolimus-eluting Resolute Onyx stent in patients with de novo coronary artery lesions: Design and rationale of the multi-center, international, randomized BIODAPTOR-RCT.
Saito S, Nef HM, Webster M, Verheye S; DynamX RCT investigators. Saito S, et al. Among authors: verheye s. Cardiovasc Revasc Med. 2023 Oct;55:76-82. doi: 10.1016/j.carrev.2023.05.010. Epub 2023 May 23. Cardiovasc Revasc Med. 2023. PMID: 37479544 Clinical Trial.
Percutaneous Coronary Treatment With Bioadaptor Implant vs Drug-Eluting Stent: 2-Year Outcomes From BIOADAPTOR RCT.
Saito S, Bennett J, Nef HM, Webster M, Namiki A, Takahashi A, Kakuta T, Yamazaki S, Shibata Y, Scott D, Vrolix M, Menon M, Möllmann H, Werner N, Neylon A, Mehmedbegovic Z, Smits PC, Morice MC, Verheye S; BIOADAPTOR-RCT Collaborators. Saito S, et al. Among authors: verheye s. JACC Cardiovasc Interv. 2025 Apr 28;18(8):988-997. doi: 10.1016/j.jcin.2025.01.426. Epub 2025 Feb 26. JACC Cardiovasc Interv. 2025. PMID: 40057888 Free article. Clinical Trial.
Coronary Sinus Narrowing for Treating Refractory Angina: REDUCER-I Multicenter "Real-World" Observational Study Primary Endpoint Analysis.
Verheye S, van de Hoef TP, de Silva R, van Kuijk JP, Byrne J, Montorfano M, Buschmann E, Dupont M, West NEJ, Banai S; REDUCER-I Study Investigators. Verheye S, et al. JACC Cardiovasc Interv. 2024 Dec 23;17(24):2908-2918. doi: 10.1016/j.jcin.2024.08.047. Epub 2024 Nov 6. JACC Cardiovasc Interv. 2024. PMID: 39520437 Free article.
Timing of Complete Multivessel Revascularization in Acute Coronary Syndrome: 2-Year Results of the BIOVASC Study.
den Dekker WK, Elscot JJ, Bennett J, Schotborgh CE, van der Schaaf R, Sabaté M, Moreno R, Ameloot K, van Bommel R, Forlani D, van Reet B, Esposito G, Dirksen MT, Ruifrok WPT, Everaert BRC, Van Mieghem C, Cummins P, Lenzen M, Brugaletta S, Boersma E, Van Mieghem NM, Diletti R; BIOVASC Investigators. den Dekker WK, et al. JACC Cardiovasc Interv. 2024 Dec 23;17(24):2866-2874. doi: 10.1016/j.jcin.2024.09.058. JACC Cardiovasc Interv. 2024. PMID: 39722269 Free article. Clinical Trial.
Heterotopic Crosscaval Transcatheter Tricuspid Valve Replacement for Patients With Tricuspid Regurgitation: The Trillium Device.
Lurz P, Kresoja KP, Besler C, Verheye S, Vermeersch P, Rudolph V, Friedrichs K, Abdul-Jawad Altisent O, Freixa X, Sanchis L, Cruz-Gonzalez I, Antunez-Muiños P, Bartunek J, Vanderheyden M, Sherif M, Trippel TD, Estevez-Loureiro R, Barreiro-Perez M, Vaknin Assa H, Kornowski R. Lurz P, et al. Among authors: verheye s. JACC Cardiovasc Interv. 2025 Jun 9;18(11):1425-1434. doi: 10.1016/j.jcin.2025.04.036. JACC Cardiovasc Interv. 2025. PMID: 40500012 Free article.
217 results